American Society of Clinical Oncology - 36th Annual Meeting.

The American Society of Clinical Oncology (ASCO) 36th Annual Meeting, which took place from 20-23 May 2000 in New Orleans, was, as usual, a large, well-attended, internationally-represented meeting of cancer specialists. Both clinical trials of well established drugs for the treatment of cancer, as well as novel agents under development were presented in poster sessions, poster discussion sessions and large oral sessions. The prominent areas of new drug development presented were anti-angiogenic agents, tyrosine kinase inhibitors, immunotherapeutics and agents that modify the pharmacology or pharmacodynamics of chemotherapeutic agents. Sessions highlighting the translational development of several compounds with other mechanisms of action were also well attended. While there were no agents with unexpectedly dramatic clinical benefit, there were a number of promising developments.